176 related articles for article (PubMed ID: 34315295)
21. Combination therapy of rituximab and mycophenolate mofetil in childhood lupus nephritis.
Hogan J; Godron A; Baudouin V; Kwon T; Harambat J; Deschênes G; Niel O
Pediatr Nephrol; 2018 Jan; 33(1):111-116. PubMed ID: 28780657
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy of rituximab therapy for 10 patients suffering from systemic lupus erythematosus with intestinal involvement].
Zhao YR; Zhao Z; Zhang J; Li KP; Yang JS; Sun F; Liao SM; Zhang JL; Huang F; Zhu J
Zhonghua Nei Ke Za Zhi; 2024 Feb; 63(2):198-202. PubMed ID: 38326047
[TBL] [Abstract][Full Text] [Related]
23. Rituximab as maintenance therapy following remission induction in relapsing or refractory systemic lupus erythematosus.
Chen X; Shi X; Xue H; Lv H; Yu L; Wu X; Wang Q; Wu H; Han F; Xue J
Rheumatology (Oxford); 2023 Mar; 62(3):1145-1152. PubMed ID: 35976105
[TBL] [Abstract][Full Text] [Related]
24. Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature.
Jovancevic B; Lindholm C; Pullerits R
Lupus; 2013 Jun; 22(7):664-74. PubMed ID: 23612795
[TBL] [Abstract][Full Text] [Related]
25. Rituximab as an effective add-on maintenance therapy for disease activities in childhood-onset systemic lupus erythematosus.
Lin TW; Lin YT; Hu YC; Yu HH; Chiang BL
Lupus Sci Med; 2024 Jan; 11(1):. PubMed ID: 38242722
[TBL] [Abstract][Full Text] [Related]
26. Rituximab therapy for childhood-onset systemic lupus erythematosus.
Willems M; Haddad E; Niaudet P; Koné-Paut I; Bensman A; Cochat P; Deschênes G; Fakhouri F; Leblanc T; Llanas B; Loirat C; Pillet P; Ranchin B; Salomon R; Ulinski T; Bader-Meunier B;
J Pediatr; 2006 May; 148(5):623-627. PubMed ID: 16737873
[TBL] [Abstract][Full Text] [Related]
27. Rituximab use in pediatric autoimmune diseases: four case reports.
Polido-Pereira J; Ferreira D; Rodrigues AM; Nascimento C; Costa P; Almeida M; da Silva JE; Simão C; Stone R; Ramos F; Neto A; da Costa JC; Melo-Gomes J; Gomes-Pedro J; Viana-Queiroz M; Canhão H; Fonseca JE
Ann N Y Acad Sci; 2009 Sep; 1173():712-20. PubMed ID: 19758220
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry.
Iaccarino L; Bartoloni E; Carli L; Ceccarelli F; Conti F; De Vita S; Ferraccioli G; Galeazzi M; Gatto M; Gerli R; Govoni M; Gremese E; Iuliano A; Mansutti E; Moroni G; Mosca M; Nalli C; Naretto C; Padovan M; Palma L; Raffiotta F; Roccatello D; Tincani A; Valesini G; Zen M; Doria A
Clin Exp Rheumatol; 2015; 33(4):449-56. PubMed ID: 26053285
[TBL] [Abstract][Full Text] [Related]
29. Rituximab in children with steroid-dependent nephrotic syndrome: experience of a tertiary center and review of the literature.
Van Horebeek I; Knops N; Van Dyck M; Levtchenko E; Mekahli D
Acta Clin Belg; 2017 Jun; 72(3):147-155. PubMed ID: 27409338
[TBL] [Abstract][Full Text] [Related]
30. Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients.
Garcia-Carrasco M; Mendoza-Pinto C; Sandoval-Cruz M; Soto-Vega E; Beltran-Castillo A; Jimenez-Hernandez M; Graillet D; Gonzalez L; Rojas-Rodriguez J; Pineda-Almazana A; Zamudio-Huerta L; Lopez-Colombo A
Lupus; 2010 Feb; 19(2):213-9. PubMed ID: 19965944
[TBL] [Abstract][Full Text] [Related]
31. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.
Olfat M; Silverman ED; Levy DM
Lupus; 2015 Aug; 24(9):966-72. PubMed ID: 25804672
[TBL] [Abstract][Full Text] [Related]
32. Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature.
Crayne CB; Eloseily E; Mannion ML; Azerf SP; Weiser P; Beukelman T; Stoll ML; Feig DI; Prescott Atkinson T; Cron RQ
Pediatr Rheumatol Online J; 2018 Nov; 16(1):71. PubMed ID: 30428889
[TBL] [Abstract][Full Text] [Related]
33. Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysis.
Duxbury B; Combescure C; Chizzolini C
Lupus; 2013 Dec; 22(14):1489-503. PubMed ID: 24135078
[TBL] [Abstract][Full Text] [Related]
34. The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus.
Kraaij T; Kamerling SWA; de Rooij ENM; van Daele PLA; Bredewold OW; Bakker JA; Bajema IM; Scherer HU; Toes REM; Huizinga TJW; Rabelink TJ; van Kooten C; Teng YKO
J Autoimmun; 2018 Jul; 91():45-54. PubMed ID: 29636274
[TBL] [Abstract][Full Text] [Related]
35. Rituximab administration during the second trimester of pregnancy for systemic lupus erythematosus: Case report and review of the literature on rheumatic disease.
Colquhoun M; Thanopoulou V; Quick V; Mouyis M
Mod Rheumatol Case Rep; 2022 Jun; 6(2):173-177. PubMed ID: 34850082
[TBL] [Abstract][Full Text] [Related]
36. Low-dose rituximab therapy in steroid-refractory thrombocytopenia due to systemic lupus erythematosus.
Ilizaliturri-Guerra O; Uriarte-Botello R; Pineda-Sic RÁ; Serna-Peña G; Garza-Elizondo MA; Galarza-Delgado DÁ; Leal-Bramasco AS; Elizondo-Solís CV; Santoyo-Fexas L; Villarreal-Alarcón MÁ
Rheumatol Int; 2020 Oct; 40(10):1717-1724. PubMed ID: 32797277
[TBL] [Abstract][Full Text] [Related]
37. Rituximab therapy for childhood onset idiopathic nephrotic syndrome: experience of a Portuguese tertiary center.
Gomes R; Mosca S; Bastos-Gomes M; Correia-Costa L; Rocha L; Teixeira A; Costa T; Sameiro-Faria M; Matos P; Mota C
J Bras Nefrol; 2023; 45(3):326-334. PubMed ID: 36259942
[TBL] [Abstract][Full Text] [Related]
38. Rituximab therapy in pediatric pemphigus patients: A retrospective analysis of five Turkish patients and review of the literature.
Bilgic-Temel A; Özgen Z; Harman M; Kapıcıoğlu Y; Uzun S
Pediatr Dermatol; 2019 Sep; 36(5):646-650. PubMed ID: 31355479
[TBL] [Abstract][Full Text] [Related]
39. The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE.
Watson L; Beresford MW; Maynes C; Pilkington C; Marks SD; Glackin Y; Tullus K
Lupus; 2015 Jan; 24(1):10-7. PubMed ID: 25117653
[TBL] [Abstract][Full Text] [Related]
40. Rituximab in Treatment of Children with Refractory Vasculitis and Systemic Lupus Erythematosus - Single Center Experience in Croatia.
Sršen S; Frković M; Malčić I; Jelušić M
Acta Dermatovenerol Croat; 2020 Aug; 28(2):63-69. PubMed ID: 32876030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
